MedPath

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Recruiting
Conditions
Pancreas Disease
Pancreatic Cyst
Registration Number
NCT03260842
Lead Sponsor
Stanford University
Brief Summary

Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.

Detailed Description

Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer.

1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol.

2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Older than 18 with pancreas cyst
  • Older than 18 at high risk for Pancreas cancer
Exclusion Criteria
  • Unable to provide consent
  • Not willing to provide bio-specimens

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pancreas Cancer5-10 years

Development of Pancreas Cancer

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

Stanford University
πŸ‡ΊπŸ‡ΈStanford, California, United States
Walter Park, MD
Contact
wgpark@stanford.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.